eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

A study for a 45-year old man who takes Plaquenil

Summary: 483 male patients aged 45 (±5) who take the same drug are studied.

This is a personalized study for a 45 year old male patient who has Rheumatoid Arthritis. The study is created by eHealthMe based on reports from FDA and social media.


On Apr, 1, 2015: 483 males aged 45 (±5) who take Plaquenil are studied

Plaquenil outcomes

Information of the patient in this study:

Age: 45

Gender: male

Conditions: Rheumatoid Arthritis

Drugs taking:
- Plaquenil (hydroxychloroquine sulfate): used for 1 - 6 months

eHealthMe real world results:

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Plaquenil is effectiven/a0.00%
(0 of 2 people)
(1 of 4 people)
(1 of 2 people)
(2 of 4 people)
(0 of 1 people)
(1 of 3 people)

Most common side effects over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Skin LesionAnxietyVision BlurredAstheniaRinging In The EarsMouth UlcerationBlood Creatine Phosphokinase IncreasedPain
UrticariaBlood Potassium DecreasedSkin RashBursitis InfectiveVision BlurredVentricular TachycardiaPyrexia
DyshidrosisEncephalopathyTinea Of The ScalpFistulaPain ManagementTroponin IncreasedArthralgia
Stevens-johnson SyndromeHeadacheCorneal ThinningArthritis BacterialDiarrhoeaRheumatoid Arthritis
Rash PruriticSkin UlcerInterstitial Lung DiseaseArthritisPyrexiaDepression
Rash ErythematousLiver Transplant RejectionCondition AggravatedUrine Lactic Acid IncreasedDyspnoea ExertionalWeight Decreased
Drug IneffectiveVomiting NosSkin Burning SensationIron Deficiency AnemiaCardiac Failure CongestiveAnxiety
Ear DisorderLip And/or Oral Cavity CancerAbdominal DiscomfortOrthopnoeaOedema Peripheral
Eosinophil Count IncreasedDrug Effect DecreasedRinging In The EarsDyspnoea Paroxysmal NocturnalChest Pain
Hepatic Enzyme IncreasedPalpitationsHemorrhoidsRenal Failure AcuteCough

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:




You are not alone! Join a related support group:
- support group for people who have Rheumatoid Arthritis
- support group for people who take Plaquenil

Recent related drug studies (Check your drugs):

Drug effectiveness in real world:

Complete drug side effects:

Alternative drugs:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.


About - Terms of service - Privacy policy - Press - Testimonials - Contact us -

© 2015 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.